SCHEMBL6320385

SCHEMBL6320385

Cc1c(-c2ccccc2)c(N2CCC2N(C)C)n2c(nc3ccccc32)c1C#N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.52
LMNA P02545 5/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
KDM4E B2RXH2 7/20 0.51
NPSR1 Q6W5P4 4/20 0.51
RXFP1 Q9HBX9 3/20 0.51
NCOA3 Q9Y6Q9 1/20 0.51
GAA P10253 4/20 0.51
GLA P06280 3/20 0.51
HPGD P15428 2/20 0.50
MAPT P10636 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HTT P42858 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
RECQL P46063 1/20 0.49
TSHR P16473 2/20 0.47
HIF1A Q16665 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL6310668 0.90 ALDH1A1 (0.47) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL6310580 0.88 ALDH1A1 (0.47) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL6313255 0.87 ALDH1A1 (0.46) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL6318152 0.86 ALDH1A1 (0.45) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL6311808 0.86 ALDH1A1 (0.45) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL6316775 0.85 ALDH1A1 (0.45) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL6317696 0.85 ALDH1A1 (0.45) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL6310820 0.84 ALDH1A1 (0.55) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL6312085 0.84 KDM4E (0.48) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL6311859 0.84 ALDH1A1 (0.44) ALDH1A1LMNAMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 ALDH1A1 2550/4885LMNA 3993/4885MEN1 2268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.